Literature DB >> 24427645

An unusual presentation of medullary thyroid carcinoma.

Sudip Kr Das1, Himanshu Varshney2, M L Saha3, Shubhrakanti Sen4, Amit Bikram Maity5, Ranjan Paul2.   

Abstract

Medullary thyroid carcinoma (MTC) is extremely uncommon having varied presentations & their prognosis is not exactly known; but as MTC is an aggressive tumor hence it needs to be documented in literature to help to know the behaviour of this variant. We report a rare presentation of medullary carcinoma of thyroid in a 48 years old man who presented with huge swelling at left side of neck extending from parotid to supraclavicular region with normal-sized thyroid gland of long duration. FNAC & incision HPE of this swelling was inconclusive so we had operated this swelling. Immunohistochemistry reported it as metastatic Medullary carcinoma of thyroid; tumor cells express Cytokeratin, Calcitonin, EMA, Synaptophysin, Chromogranin-A. The stroma shows deposits of Amyloid, which have been confirmed by Congo red staining. Post-operatively FNAC from thyroid gland supported the diagnosis of Medullary carcinoma. Post-operatively the residual mass was regressed with chemotherapy & radiotherapy. The calcitonin level also decreased following this treatment. There was no recurrence at 11 months but ultimately patient died with metastasis.

Entities:  

Keywords:  Medullary thyroid carcinoma; Neck mass; Unknown primary

Year:  2013        PMID: 24427645      PMCID: PMC3718962          DOI: 10.1007/s12070-013-0624-z

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  8 in total

1.  Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity.

Authors:  J B HAZARD; W A HAWK; G CRILE
Journal:  J Clin Endocrinol Metab       Date:  1959-01       Impact factor: 5.958

2.  Cytological aspects of melanotic variant of medullary thyroid carcinoma.

Authors:  M A de Lima; J Dias Medeiros; L Rodrigues Da Cunha; R de Cássia Caldas Pessôa; F Silveira Tavares; M de Fátima Borges; E O Marinho
Journal:  Diagn Cytopathol       Date:  2001-03       Impact factor: 1.582

3.  Long term prognosis of medullary thyroid carcinoma in 39 patients.

Authors:  P E Voutilainen; M Multanen; R K Haapiainen; C H Haglund; T Sane; A H Sivula
Journal:  Ann Chir Gynaecol       Date:  2000

4.  Medullary thyroid cancer: multivariate analysis of prognostic factors influencing survival.

Authors:  S L Hyer; L Vini; R A'Hern; C Harmer
Journal:  Eur J Surg Oncol       Date:  2000-11       Impact factor: 4.424

5.  Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma.

Authors:  S Franc; P Niccoli-Sire; R Cohen; S Bardet; B Maes; A Murat; A Krivitzky; E Modigliani
Journal:  Clin Endocrinol (Oxf)       Date:  2001-09       Impact factor: 3.478

6.  Molecular genotyping of medullary thyroid carcinoma can predict tumor recurrence.

Authors:  Hina A Sheikh; Michael Tometsko; Laura Niehouse; Dalal Aldeeb; Patricia Swalsky; Sydney Finkelstein; E Leon Barnes; Jennifer L Hunt
Journal:  Am J Surg Pathol       Date:  2004-01       Impact factor: 6.394

7.  Medullary carcinoma of the thyroid gland. Clinical, pathological, and immunohistochemical features with review of the literature.

Authors:  M Uribe; C M Fenoglio-Preiser; M Grimes; C Feind
Journal:  Am J Surg Pathol       Date:  1985-08       Impact factor: 6.394

8.  Melanotic medullary carcinoma of thyroid--report of a rare case with brief review of literature.

Authors:  Kamaljeet Singh; Mehar C Sharma; Deepali Jain; Rajinder Kumar
Journal:  Diagn Pathol       Date:  2008-01-11       Impact factor: 2.644

  8 in total
  1 in total

1.  Initial clinical presentation of single soft tissue metastasis of medullary thyroid carcinoma without primary tumor in the thyroid gland.

Authors:  Masanori Okamoto; Akira Takazawa; Kaoru Aoki; Yasuo Yoshimura; Hiroyuki Kato; Toshiaki Otsuki; Kazuma Maeno; Tomonobu Koizumi
Journal:  World J Surg Oncol       Date:  2017-12-13       Impact factor: 2.754

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.